Ionis Pharmaceuticals (IONS) Income from Non-Controlling Interests (2009 - 2020)

Ionis Pharmaceuticals' Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at -$1.2 million for Q4 2020.

• In Q4 2020, Income from Non-Controlling Interests fell 105.91% year-over-year to -$1.2 million; the TTM figure through Sep 2021 stood at -$1.2 million (up 92.19% YoY), while the FY2020 annual figure was -$35.5 million, down 489.21% from the prior year.
• Income from Non-Controlling Interests was -$1.2 million for Q4 2020 at Ionis Pharmaceuticals, up from -$12.1 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $19.5 million in Q4 2019 to a low of -$17.3 million in Q4 2018.
• Historically, Income from Non-Controlling Interests has averaged -$6.9 million across 4 years, with a median of -$9.3 million in 2018.
• The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests soared 212.67% in 2019, then plunged 259.2% in 2020.
• A 4-year view of Income from Non-Controlling Interests shows it stood at -$6.2 million in 2017, then sank by 177.64% to -$17.3 million in 2018, then jumped by 212.67% to $19.5 million in 2019, then tumbled by 105.91% to -$1.2 million in 2020.
• The last three Income from Non-Controlling Interests figures came in at -$1.2 million (Q4 2020), -$12.1 million (Q3 2020), and -$11.9 million (Q2 2020), per Business Quant data.